Purchase Order 75N95018P00514

Award Date 8/20/18
Potential Completion Date 8/31/18
Potential Value $13K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to AAT Bioquest, Inc., a minority-owned, for-profit, woman-owned small business, and Asian-Pacific American-owned manufacturer of goods. The contract, valued at $161,032.00, is for products or services related to the NIH's mission of accelerating the translation of research to improve human health. The contract does not have a set-aside designation and...
<p>This federal contract, awarded by the National Center for Advancing Translational Sciences, a civilian agency, to A1 Biochem Labs LLC, provides for the non-GMP scale up synthesis of a specific chemical compound. The contract is a firm fixed price purchase order with a ceiling value of $24,852.00 and a completion date of October 17, 2024. The contract does not have a set-aside designation. No information is provided about any subcontractors involved in this effort.</p>
<p>This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to AAT Bioquest, Inc. The contract is for the labeling of RNaseB and streptavidin proteins for an NGLY1 project. The total potential value of the contract is $24,800.00. AAT Bioquest, Inc. is a minority-owned, woman-owned small business that manufactures goods. The contract does not have a set-aside designation.</p>
<p>This is a $92,334.95 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences, a civilian agency, to Apexbio Technology, LLC, a small business, for the delivery of 2,234 compounds of 5mg size. The contract has a completion date of July 20, 2015. This contract award is not associated with a larger contract vehicle.</p>
This is a federal contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Compound Focus Inc. for the operation and maintenance of the NCATS Small Molecule Repository. The contract has a ceiling value of $2,093,753.88 and was awarded on June 14, 2016, with a period of performance through June 13, 2017. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type, and there is no set-aside designation. The contract is not...
This is a $447,635.80 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. government. The contract is for the &quot;SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)&quot; program and was awarded to Analyticon Discovery, LLC, a for-profit foreign-owned organization. The contract does not have a set-aside designation and has an ultimate completion date of January 31, 2016. NCATS is...
This is a firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences, a civilian federal agency, to Transomic Technologies, Inc. for $49,950.00. The contract has an ultimate completion date of December 31, 2015 and was not set aside. The contract does not appear to be associated with a larger contracting vehicle, and the provided information does not indicate any major subcontractors. Based on the agency, the contract is likely related to the National...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $42,840.00 firm fixed price purchase order to AAT Bioquest, Inc., a minority-owned, woman-owned small business, for the delivery of 20 units of the Screen Quest Calbryte-520 Probenecid-Free and Wash-Free Calcium Assay Kit. This requirement was solicited and awarded on a non-competitive basis for a commercial item under simplified acquisition procedures. The...
This is a $90,075 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to American Biochemicals Inc. The contract is for the synthesis of approximately 50 analogs of the small molecule compound metarrestin, which is being developed as an anti-metastasis agent for pancreatic cancer. The goal is to reduce the brain exposure of the compounds while maintaining their...
This is a Cost Plus Fixed Fee delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH), a civilian federal agency. The contract, with a ceiling value of $2,391,161.12, is for the procurement of new equipment for the NIH Small Molecule Repository program. The prime contractor is Compound Focus Inc., and the place of performance is South San Francisco, California. The contract does not have a...

This federal contract award was issued by the National Center for Advancing Translational Sciences, a civilian agency, to AAT Bioquest, Inc. The contract has a ceiling value of $12,570.00 and is a Firm Fixed Price Purchase Order with an ultimate completion date of August 31, 2018. The contract does not have a set-aside designation. Based on the agency and description, this contract is likely related to the agency's research and development efforts in the field of translational sciences.

Generated 7/10/24, 9:52 AM